PFE · News · 20260807N

AI Adoption Recognition

PFIZER INC · 2026-08-07 · Importance 31 · Surprise 42

Pfizer is positioning artificial intelligence as a technology for drug discovery, clinical development and manufacturing. CEO Albert Bourla described plans to structure 177 years of company data and federate AI across the organization. Pfizer also intends to build AI fluency among employees rather than limit adoption to specialized technical teams. The company expects AI to establish a new standard of care within five years and materially change medicine over the following decade.

Key facts

• Albert Bourla outlined three AI strategies for Pfizer: structuring 177 years of data, federating AI across the organization, and investing in AI fluency for all colleagues. source
• Albert Bourla stated he believes AI will fundamentally transform medicine discovery, development, and manufacturing, leading to a new standard of care within five years and entirely changing what medicine can do in the decade beyond. source